Search Results - "Gergei, Ingrid"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Cardiovascular risk algorithms in primary care: Results from the DETECT study by Grammer, Tanja B., Dressel, Alexander, Gergei, Ingrid, Kleber, Marcus E., Laufs, Ulrich, Scharnagl, Hubert, Nixdorff, Uwe, Klotsche, Jens, Pieper, Lars, Pittrow, David, Silber, Sigmund, Wittchen, Hans-Ulrich, März, Winfried

    Published in Scientific reports (31-01-2019)
    “…Guidelines for prevention of cardiovascular diseases use risk scores to guide the intensity of treatment. A comparison of these scores in a German population…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Circulating Sclerostin Levels Are Positively Related to Coronary Artery Disease Severity and Related Risk Factors by Frysz, Monika, Gergei, Ingrid, Scharnagl, Hubert, Smith, George Davey, Zheng, Jie, Lawlor, Deborah A, Herrmann, Markus, Maerz, Winfried, Tobias, Jon H

    Published in Journal of bone and mineral research (01-02-2022)
    “…ABSTRACT Romosozumab is a newly available treatment for osteoporosis acting by sclerostin inhibition. Its cardiovascular safety has been questioned after…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Renal function, N-terminal Pro-B-Type natriuretic peptide, propeptide big-endothelin and patients with heart failure and preserved ejection fraction by Gergei, Ingrid, Krämer, Bernhard K., Scharnagl, Hubert, Stojakovic, Tatjana, März, Winfried

    Published in Peptides (New York, N.Y. : 1980) (01-01-2019)
    “…•NT-proBNP is strongly associated with GFR.•Three different cut-off values for NT-proBNP may be needed for the diagnosis of HFpEF in CKD patients.•Big-ET-1 is…”
    Get full text
    Journal Article
  6. 6

    Association of soluble CD40L with short-term and long-term cardiovascular and all-cause mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study by Gergei, Ingrid, Kälsch, Thorsten, Scharnagl, Hubert, Kleber, Marcus E., Zirlik, Andreas, März, Winfried, Krämer, Bernhard K., Kälsch, Anna-Isabelle

    Published in Atherosclerosis (01-12-2019)
    “…The CD40−CD40 Ligand (CD40L) system has an important role in vascular inflammation. For this reason, we assessed the association of soluble CD40L with…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Platelet and Monocyte Activity Markers and Mortality in Patients with End-Stage Renal Disease by Gergei, Ingrid, Kälsch, Thorsten, März, Winfried, Krämer, Bernhard K, Kälsch, Anna-Isabelle

    Published in Clinical laboratory (Heidelberg) (01-01-2020)
    “…The association of platelet and monocyte activity markers with long-term mortality was assessed in hemodialysis (HD) patients. In 41 HD patients (25 male, 16…”
    Get more information
    Journal Article
  13. 13

    Propeptide big-endothelin, N-terminal-pro brain natriuretic peptide and mortality. The Ludwigshafen risk and cardiovascular health (LURIC) study by Gergei, Ingrid, Krämer, Bernhard K., Scharnagl, Hubert, Stojakovic, Tatjana, März, Winfried, Mondorf, Ulrich

    Published in Biomarkers (19-05-2017)
    “…Context: The endothelin system (Big-ET-1) is a key regulator in cardiovascular (CV) disease and congestive heart failure (CHF). Objectives: We have examined…”
    Get full text
    Journal Article
  14. 14

    Chronic kidney disease in primary care in Germany by Gergei, Ingrid, Klotsche, Jens, Woitas, Rainer P., Pieper, Lars, Wittchen, Hans-Ulrich, Krämer, Bernhard K., Wanner, Christoph, Mann, Johannes F. E., Scharnagl, Hubert, März, Winfried, Mondorf, Ulrich

    Published in Journal of public health (01-04-2017)
    “…Aims The continuing growth of the population with end-stage renal disease (ESRD) in the past two decades has been recognized as a global health burden. In…”
    Get full text
    Journal Article